
Louis Samuel Williams MD MBA
Hematologic Oncology
Associate Staff, Hematology &Medical Oncology
Join to View Full Profile
Cleveland Clinic Taussig Cancer CenterCa Building 10201 Carnegie AvenueCleveland, OH 44106
Phone+1 412-719-9164
Dr. Williams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Louis Williams is a hematologist in Cleveland, OH and is affiliated with Cleveland Clinic. He received his medical degree from Albany Medical College, completed internal medicine training at the Cleveland Clinic, and his fellowship in hematology and medical oncology at the New York University Grossman School of Medicine. He holds an MBA from Yale University School of Management. He has been in practice for 4 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematopoietic stem cell transplantation, cellular therapy, multiple myeloma, and scleromyxedema. He has more than 30 publications and over 150 citations.
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2018 - 2021
Cleveland Clinic FoundationResidency, Internal Medicine, 2015 - 2018
Albany Medical CollegeClass of 2015
Certifications & Licensure
OH State Medical License 2015 - 2027
NY State Medical License 2019 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Current management of non-amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomes.Daniel Cancilla, Hanny Sawaf, Xuefei Jia, Danai Dima, Ali Mehdi
British Journal of Haematology. 2025-10-23 - Management of relapsed refractory multiple myeloma: Evidence-based guide to community oncologists.Ali Mushtaq, Asfand Yar Cheema, Hossam M Ali, Yara Shatnawi, Omer Ashruf
Blood Reviews. 2025-09-27 - 1 citationsA multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes.Dylan C Gagler, Hussein Ghamlouch, Di Zhang, Patrick Blaney, Avital Tenenbaum
Blood. 2025-09-04
Journal Articles
- Deep sequencing as an approach to understanding the complexity and improving the treatment of multiple myelomaLouis Williams, Jessica Caro, Beatrice Razzo, Eileen Boyle & Gareth J. Morgan, Expert Review of Precision Medicine and Drug Development, 7/7/2020
Press Mentions
ASH 2018: Dec 1-4December 1st, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









